🇧🇪
Western EuropeBelgium
Belgium is a biotech powerhouse relative to its size, with Ghent as a globally recognized hub for cell and gene therapy. UCB, Galapagos, and argenx have put Belgium on the biotech map.
Biotech Market Cap
$71.9B
Public Companies
7
Total Companies
134
30D Performance
-5.68%
BIOTECH MARKET CAP INDEX
$71.9B+6353.9%ALL
BIOTECH HUBS
GhentLeuvenBrusselsMechelen
COMPANIES
| # | Company | Valuation |
|---|---|---|
| 1 |  | $56.2B |
| 2 |  | $11.1B |
| 3 |  | $2.0B |
| 4 |  | $1.8B |
| 5 |  | $623.1M |
| 6 |  | $156.7M |
| 7 |  | $991 |
| 8 |  | — |
| 9 |  | — |
| 10 |  | — |
| 11 |  | — |
| 12 |  | — |
| 13 |  | — |
| 14 |  | — |
| 15 |  | — |
| 16 |  | — |
| 17 |  | — |
| 18 |  | — |
| 19 |  | — |
| 20 |  | — |
Showing 1–20 of 134 companies
Page 1 of 7